These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24103908)

  • 1. Anti-brain autoantibodies in the serum of schizophrenic patients: a case-control study.
    Margari F; Petruzzelli MG; Mianulli R; Toto M; Pastore A; Bizzaro N; Tampoia M
    Psychiatry Res; 2013 Dec; 210(3):800-5. PubMed ID: 24103908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating anti-brain autoantibodies in schizophrenia and mood disorders.
    Margari F; Petruzzelli MG; Mianulli R; Campa MG; Pastore A; Tampoia M
    Psychiatry Res; 2015 Dec; 230(2):704-8. PubMed ID: 26548982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anti-cerebral autoantibodies in schizophrenia and Alzheimer's disease.
    Sugiura M; Yokoi Y; Maruyama S; Ishido T; Tokunaga Y; Sasaki K
    J Clin Lab Immunol; 1989 Jan; 28(1):1-3. PubMed ID: 2657070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association between HSV-2 infection and serum anti-rat brain antibodies in patients with autism].
    Mora M; Quintero L; Cardenas R; Suárez-Roca H; Zavala M; Montiel N
    Invest Clin; 2009 Sep; 50(3):315-26. PubMed ID: 19961054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients' sera.
    Borda T; Gomez R; Berría MI; Sterin-Borda L
    Glia; 2004 Jan; 45(2):144-54. PubMed ID: 14730708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indirect immunofluorescence and complement absorption test characterization of anti-brain antibodies in schizophrenia].
    Mogilina NP; Zhirnova IG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):397-401. PubMed ID: 7020298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular and circulating neuronal antinuclear antibodies in human epilepsy.
    Iffland PH; Carvalho-Tavares J; Trigunaite A; Man S; Rasmussen P; Alexopoulos A; Ghosh C; Jørgensen TN; Janigro D
    Neurobiol Dis; 2013 Nov; 59():206-19. PubMed ID: 23880401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia.
    Jones AL; Mowry BJ; McLean DE; Mantzioris BX; Pender MP; Greer JM
    J Neuroimmunol; 2014 Apr; 269(1-2):68-75. PubMed ID: 24636402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinuclear autoantibodies in chronic schizophrenia.
    Spivak B; Radwan M; Bartur P; Mester R; Weizman A
    Acta Psychiatr Scand; 1995 Oct; 92(4):266-9. PubMed ID: 8848951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune liver disease-related autoantibodies in patients with biliary atresia.
    Pang SY; Dai YM; Zhang RZ; Chen YH; Peng XF; Fu J; Chen ZR; Liu YF; Yang LY; Wen Z; Yu JK; Liu HY
    World J Gastroenterol; 2018 Jan; 24(3):387-396. PubMed ID: 29391761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients--part I: young subjects.
    Spivak B; Schechtman M; Blumensohn R; Schonherz-Pine Y; Yoran-Hegesh R; Deckmann M; Mayer R; Weizman A; Shinitzky M
    Neuropsychobiology; 2009; 60(1):44-8. PubMed ID: 19729972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients--part II: adult subjects.
    Spivak B; Schechtman M; Schonherz-Pine Y; Blumensohn R; Mostovoy S; Amital D; Deckmann M; Weizman A; Shinitzky M
    Neuropsychobiology; 2009; 60(1):49-54. PubMed ID: 19729973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody reactivity to brain membrane proteins in serum from schizophrenic patients.
    Sundin U; Thelander S
    Brain Behav Immun; 1989 Dec; 3(4):345-58. PubMed ID: 2611415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods.
    Mahler M; Silverman ED; Fritzler MJ
    Lupus; 2010 Nov; 19(13):1527-33. PubMed ID: 20647252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetric complications and autoantibodies in schizophrenia.
    Chengappa KN; Nimgaonkar VL; Bachert C; Yang ZW; Rabin BS; Ganguli R
    Acta Psychiatr Scand; 1995 Oct; 92(4):270-3. PubMed ID: 8848952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of antibrain antibodies in the sera from schizophrenic patients.
    Henneberg AE; Horter S; Ruffert S
    Schizophr Res; 1994 Dec; 14(1):15-22. PubMed ID: 7893617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
    Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
    Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies.
    Sühs KW; Skripuletz T; Pul R; Alvermann S; Schwenkenbecher P; Stangel M; Müller-Vahl K
    Mol Brain; 2015 Oct; 8(1):62. PubMed ID: 26462472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies characterizing 60 kda autoantibodies in subjects with schizophrenia.
    Wang XF; Wang D; Zhu W; Delrahim KK; Dolnak D; Rapaport MH
    Biol Psychiatry; 2003 Mar; 53(5):361-75. PubMed ID: 12614989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for the presence of neuronal surface autoantibodies in plasma of patients with schizophrenia.
    van Mierlo HC; van Coevorden-Hameete MH; Munting LP; de Graaff E; de Witte L;
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2326-32. PubMed ID: 26482911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.